AMPEL BioSolutions
Business Services · Virginia, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
250 W Main St Ste 300, Charlottesville, ...Phone Number
(434) 296-2675Website
www.ampelbiosolutions.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About AMPEL BioSolutions
AMPEL BioSolutions specializes in personalized precision medicine, focusing on dynamic disease management of autoimmune and inflammatory diseases through RNA analytics and predictive AI. Their AMPEL Genomic Platform (AGP) supports genomic blood and biopsy tests to evaluate disease status, identify cellular functions, and predict flares and drug targets. The company offers clinical products such as LuGENE, with future products like DermaGENE and WellGENE planned for release. AMPEL serves a diverse range of clients, including patients and healthcare providers, across various medical fields such as lupus, dermatology, cardiology, and nephrology.Explore more
AMPEL BioSolutions Org Chart
PL
Founder and Chief Medical Officer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AMPEL BioSolutions your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if AMPEL BioSolutions is spiking on competitors!
Click to see if AMPEL BioSolutions had a recent Job posting/layoffs
AMPEL BioSolutions, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at AMPEL BioSolutions
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once AMPEL BioSolutions has new funding data
Earning: See what the market has to say on AMPEL BioSolutions recently announced quarterly report
Check if AMPEL BioSolutions has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when AMPEL BioSolutions launches new products
Recommended Actions
Find VP level buyers at AMPEL BioSolutions
Find 2 more new buyers
Compare Similar Companies to AMPEL BioSolutions
Compare insights from companies similar to AMPEL BioSolutions, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
AMPEL BioSolutions
<$5M
11-50
Private
-
2013
AG
Amrie GrammerFounder & President & Chief Scientific Officer
Company Profile Activity
Activity Insights
AMPEL BioSolutions is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
AMPEL BioSolutions is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about AMPEL BioSolutions.
AMPEL BioSolutions Tech Stack
A closer look at the technologies used by AMPEL BioSolutions
AMPEL BioSolutions News & Media
AMPEL BioSolutions' Breakthrough Predicts Drug Options to Slow End Stage Renal Disease
CHARLOTTESVILLE, Va., March 1, 2023 /PRNewswire/ -- AMPEL BioSolutions today announced a genomic precision medicine test for chronic kidney diseases, such as Lupus Nephritis, that could save lives by predicting kidney damage before it is irreversible and providing decision support for...AMPEL BioSolutions' Breakthrough Predicts Drug Options for Fibromyalgia
CHARLOTTESVILLE, Va., Jan. 31, 2023 /PRNewswire/ -- AMPEL BioSolutions today announces a breakthrough in precision and personalized medicine that could revolutionize the way doctors treat chronic pain syndromes, such as fibromyalgia. Revealed in the peer-reviewed journal Lupus Science and...EARLY GENETIC TESTING PREDICTS HEART DISEASE AND NOVEL THERAPIES FOR WOMEN WITH LUPUS
CHARLOTTESVILLE, Va., Nov. 4, 2022 /PRNewswire/ -- AMPEL BioSolutions today announced a genetic precision medicine test for lupus patients that could save lives by predicting heart disease before it happens and providing decision support for prophylactic therapies. Shared genes that...NEW BREAKTHROUGH TEST DETECTS AND PREDICTS SEVERITY OF COVID-19
CHARLOTTESVILLE, Va., Sept. 15, 2022 /PRNewswire/ -- AMPEL BioSolutions today announced a breakthrough in precision and personalized medicine that can detect and predict the severity of COVID-19 in patients while also determining the best treatment options for each specific case. The...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding AMPEL BioSolutions
Sign Up For FreeTo access detailed company insights
AMPEL BioSolutions specializes in personalized precision medicine, focusing on dynamic disease management of autoimmune and inflammatory diseases through RNA analytics and predictive AI. Their AMPEL Genomic Platform (AGP) supports genomic blood and biopsy tests to evaluate disease status, identify cellular functions, and predict flares and drug tar... Read More
